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Cod liver oil (CLO) is a food supplement extracted from 
the cod liver. Cod liver oil has long been used as medicine 
or as a functional food. Cod liver oil is a potential source 
of vitamin D, vitamin A, and omega fatty acids 
(eicosapentaenoic acid/EPA and docosahexaenoic 
acid/DHA)1. Cod liver oil can prevent heart disease by 
increasing the elasticity of blood vessels, lowering blood 
pressure, reducing lipid level, and increasing the HDL 
level2-4. Cod liver oil can support the treatment of type II 
diabetes mellitus (T2DM) by increasing insulin 
sensitivity5. Other studies have shown that CLO has 
cytotoxic, neuroprotective, hepatoprotective, anti-ulcer, 
and anti-inflammatory activities. Cod liver oil can also 
help brain development for children's growth6,7. 
In oral use, CLO is generally developed as an Emulsion-
based delivery system. In the oil in a water emulsion 
system, CLO is in a dispersed form that is coated or 
protected by water8,9. The emulsion form of CLO is 
further modified into a nanoemulsion form10,11. The 
advantage of the nanoemulsion system is has a small 
globule size (nano-scale) and increasing its absorption 
and bioavailability12. However, the study that develops 
cod liver oil into another form of nanoemulsion system: 
The self-nanoemulsifying drug delivery system 
(SNEDDS), has not been carried out. 
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Cod liver oil (CLO) has long been used as medicine or as a functional 
food. The CLO is a potential source of vitamin D, vitamin A, and 
omega fatty acids (eicosapentaenoic acid/EPA and docosahexaenoic 
acid/DHA). Self-nanoemulsifying drug delivery system (SNEDDS) 
can enhance dissolution, absorption, and bioavailability of hydrophilic 
and lipophilic substances for oral administration. The objective of this 
study was to develop a SNEDDS of CLO with good physical 
characteristics and stability. The optimization formula was carried out 
using various ratios of oil, surfactant, and cosurfactant. The physical 
properties of SNEDDS were determined by transmittance percentage, 
dispersibility, robustness, thermodynamics stability (heating-cooling 
cycle, centrifugation, and freeze-thaw cycle), and globule size 
distribution. The optimum formula of CLO-SNEDDS was obtained at 
a ratio of surfactant and cosurfactant 2 : 1  and a comparison of oil and 
surfactant mixtures 1 : 6. The CLO-SNEDDS meets the requirement of 
percent transmittance (97.90±0.85), dispersibility (grade A), and 
stability based on robustness and thermodynamic stability tests. 
Diluted SNEDDS has an average globule size of 125 nm with a 
polydispersity index (PDI) of 0.515. CLO-SNEDDS preparation has 
good physical characteristics and stability. 
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In this study, CLO was developed in SNEDDS. The 
SNEDDS is a preconcentrated or anhydrous form of 
nanoemulsion, a mixture of oils, surfactants, and 
cosurfactants13. This system is expected to self-emulsify 
quickly in the aqueous stomach system and produces 
nano globules with a size of 20-200 nm. The advantages 
of SNEDDS over nanoemulsion are enhancing the 
physical and chemical stability of the formulation and the 
ability to fill them into unit dosage forms, such as 
soft/hard capsules, which improves their commercial 
viability and patient compliance14. 
Several studies have been carried out to develop 
SNEDDS for lipophilic active compounds. The results 
show that SNEDDS can increase the absorption and 
bioavailability of active compounds in oral delivery15,16. 
This study aimed to develop SNEDDS of CLO for oral 
delivery. Physical and stability evaluations were carried 
out to the preparations. 
 
MATERIALS AND METHODS 
Materials 
The materials used in this study were COD (Lancida 
Hebar Technology), Cremophor®RH-40 (BASF), 
polyethylene glycol (PEG) 400 (Bratachem), and 
monopotassium phosphate/KH2PO4 (Merck). The 
main instruments used in this study were gas 
chromatography-mass spectrometry/GC-MS 
(Shimadzu GCMS-QP2010 Ultra), magnetic stirrer 
(Thermolyne S131120-33Q), particle size analyzer/PSA 
(Beckman Coulter), spectrophotometer UV-Vis 
(Shimadzu UV mini-1240), sonicator (Branson), 
analytical balance (Mettler Toledo AL204), dan vortex 
mixer (Thermo Scientific). 
Methods 
The research was carried out in several stages of the 
method as shown in Figure 1. 
 
Figure 1. Research flow chart 
 
Miscibility study of oil and surfactant/co-surfactant 
The test was carried out by the miscibility study between 
CLO and surfactant/cosurfactant. The surfactants used 
were Cremophor®RH-40 and Tween 80; the cosurfactant 
used was propylene glycol, Transcutol®, and PEG 400. 
Miscibility studies were performed by preparing 1 mL of 
the CLO in a test tube then added with 
surfactant/cosurfactant until a clear mixture was 
obtained. Stirring and observation were provided every 
time addition of 1 mL of surfactant/cosurfactant17. 
Optimization of surfactant and cosurfactant ratio for CLO-
SNEDDS 
At this stage, the SNEDDS formula was optimized by 
varying the concentration of surfactants and 
cosurfactants at a ratio of oil and Smix (surfactant + 
cosurfactant) was 1 : 9. Comparison of surfactant and 
cosurfactant used was 3 : 1; 2 : 1; and 3 : 2. The SNEDDS 
prepared by mixing oil, surfactant, and co-surfactant at a 
temperature of 40°C, then stirred until homogeneous. 
The CLO-SNEDDS preparations were characterized by 
the percent transmittance test18. 
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Physical evaluation of CLO-SNEDDS 
Percent transmittance – As much as 1 mL of each SNEDDS 
preparation was diluted up to 100 mL using distilled 
water. Measurement was carried out at a wavelength of 
650 nm using a UV-Vis spectrophotometer. Distilled 
water was used as blank19. 
Dispersibility test – A dispersibility test was performed 
using a type II dissolution apparatus. As much as 1 mL of 
CLO-SNEDDS was added to the 250 mL of distilled 
water and stirred at 37±0.5ºC at 50 RPM. Visual 
observation was carried out according to the 
emulsification grade, as shown in Table I17,20. 
Table I. Grade of dispersibility 
Grade Specification 
A Rapidly forming emulsion, with a clear or bluish 
appearance 
B Rapidly forming with slightly less clear emulsion, 
with a bluish-white appearance 
C Fine milky emulsion 
D Slow to emulsify, dull, greyish white emulsion 
having a slightly oily appearance 
E Poor or minimal emulsification with large oil 
droplets on the surface 
 
Robustness to dilution test – Robustness tests were carried 
out by diluting 1 mL of each CLO-SNEDDS with 100 mL 
of distilled water, 0.1 N HCl, and phosphate buffer pH 
6.8. The mixtures were stirred using a magnetic stirrer 
and then stored for 24 hours to observe any physical 
change of system, including phase separation and 
precipitation21,22. 
Determination of droplet size and polydispersity index – 
Droplet size and polydispersity index were determined 
using a PSA. The test was carried out on the diluted CLO-
SNEDDS. A total of 100 μL of CLO-SNEDDS was diluted 
with 50 mL of distilled water23. 
Thermodynamic stability study – The stability was 
evaluated by centrifugation, a heating-cooling cycle, and 
a freeze-thaw cycle. Centrifugation tests were carried out 
at 3,500 RPM for 30 minutes. At heating cooling tests, 
CLO-SNEDDS were stored at two different 
temperatures (45 and 4ºC). The tests were carried out in 
three cycles with storage at each temperature for not less 
than 48 hours. The freeze-thaw tests were carried out at 
two different temperatures: -21 and 25ºC, conducted for 
three cycles with storage at each temperature for not less 
than 48 hours24. 
 
RESULTS AND DISCUSSION 
The SNEDDS was known to be one of the nano-based 
drug delivery systems suitable for the delivery of 
hydrophilic or lipophilic compounds. The CLO delivery 
in SNEDDS was expected to increase its dissolution, 
absorption, and bioavailability. The SNEDDS was 
prepared by mixing oil, surfactants, and cosurfactants 
without adding water, so SNEDDS was also known as a 
preconcentrated or anhydrous form of nanoemulsion13. 
The SNEDDS would form a nanoemulsion system 
spontaneously by gastrointestinal (GI) peristaltic. 
Miscibility of oil with surfactants and cosurfactants was 
important for the effectiveness of SNEDDS formation. 
The result showed that CLO has good miscibility 
property with Cremophor®RH-40 and PEG 400. 
Surfactants and cosurfactants in the nanoemulsion were 
used to form a good and flexible interfacial film and 
decrease surface tension value to almost zero and 
support the spontaneous formation of nano globules25, as 
shown in Table II. 
Table II. Result of CLO miscibility study 
Type Substance Ratio Miscibility 
Surfactant Tween 80 1 : 6 
 Cremophor®RH-40 1 : 5 
Cosurfactant PEG 400 1 : 4 
 Propylene glycol 1 : 6 
 Trancutol 1 : 7 
 
The first step of the optimization formula was to 
determine the optimum ratio of the surfactant and the 
cosurfactant. Surfactants and cosurfactants used were 
Cremophor®RH-40 and PEG 400. The percent 
Priani SE, Rahayu DP, Maulana IT. 2021. Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Oral Delivery of Cod Liver Oil 
131 
transmittance test was used as the initial screening 
method to select the optimum ratio of surfactants and 
cosurfactants. The result showed that formula F2 (2 : 1) 
had a percent transmittance value closest to 100%, as 
shown in Table III. Therefore, the 2 : 1 ratio of surfactant 
and cosurfactant was used for the following research 
step. 
Table III. Optimization result of ratio surfactant and 
cosurfactant 
Formula Oil : Smix S : CoS %transmittance 
F1 1 : 9 3 : 1 98.00±0.01 
F2 1 : 9 2 : 1 99.60±0.06 
F3 1 : 9 3 : 2 98.70±0.26 
 
The next step was carried out to determine the optimum 
ratio of oil and smix using the percent transmittance test 
as an initial screening. The result showed that F2A, F2B, 
F2C, F2D, and F2E meet the percent transmittance 
requirement for SNEDDS (>90%), as shown in Table 
IV26. Therefore, the five formulas of CLO-SNEDDS were 
continued for further evaluation. 
Table IV. Optimization result of ratio oil and smix 
Formula Oil : Smix S : CoS %transmittance 
F2A 1 : 9 2 : 1 99.60±0.06 
F2B 1 : 8 2 : 1 98.80±0.05 
F2C 1 : 7 2 : 1 97.53±0.32 
F2D 1 : 6 2 : 1 97.90±0.85 
F2E 1 : 5 2 : 1 95.76±0.25 
F2F 1 : 4 2 : 1 39.00±3.21 
 
Dispersibility tests, robustness tests, and thermodynamic 
stability tests were carried out on F2A, F2B, F2C, F2D, and 
F2E, as shown in Table V. The objective of dispersibility 
tests was to determine the ability of SNEDDS to disperse 
entirely and quickly when subjected to dilution under 
mild agitation. The test was carried out by visual 
observation, and then the grade was determined 
according to Table I. The SNEDDS preparations must 
exhibit grade A and B characteristics on the dispersibility 
test. The CLO-SNEDDS (F2A-F2E) could quickly 
produce a clear emulsion (nanoemulsion) system when 
diluted in water so that it was categorized as grade A in 
the dispersibility test. The ability of SNEDDS to form 
nanoemulsion spontaneously when diluted in water 
occurs due to the presence of surfactants and 
cosurfactants that were capable of forming an interfacial 
layer in the nano globules system27. 
The purpose of the robustness test was to determine the 
system's stability after the SNEDDS preparation is 
diluted in three types of solvents with different pH 
values, like in the digestive tract conditions. The solvents 
used were distilled water medium, HCl 0.1 N (stomach 
condition), and a phosphate buffer pH 6.8 (small intestine 
condition). The results showed that CLO-SNEDDS was 
able to form a stable system after dilution, using the three 
types of solvents, characterized by the absence of phase 
separation and precipitation28. 
The subsequent study was the thermodynamic stability 
test, carried out by three types of tests (centrifugation, 
heating cooling, and freeze-thaw). The results showed 
that CLO-SNEDDS (F2A, F2B, F2C, and F2D) had good 
stability marked by not occurring phase separation and 
sedimentation. This indicates that the CLO-SNEDDS 
(F2A, F2B, F2C, and F2D) had good kinetic and 
thermodynamic stability. The F2E formula shows 
instability in thermodynamic testing, which could occur 
because the number of surfactants and cosurfactants was 
insufficient to form a stable nanoemulsion system29. 
Based on the dispersibility, robustness, and 
thermodynamic test, it could be concluded that CLO-
SNEDDS (F2A, F2B, F2C, and F2D) had good physical 
characteristics. Formula F2D with a ratio of oil and smix 
1 : 6 was chosen as the final formula (Figure 2). The 
formula was chosen because it still produces SNEDDS 
with good physical characteristics, with the least amount 
of smix. This was expected can minimize the risk of 
negative effects of surfactants and cosurfactants for oral 
administration. 
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Table V. Dispersibility, robustness, and thermodynamic stability tests results 
Evaluation F2A F2B F2C F2D F2E 
Dispersibility Emulsification time (s) 35.30±0.55 33.83±0.32 34.30±0.61 35.86±2.52 43.73±0.38 
Appearance Clear Clear Clear Clear Clear 
Grade A A A A A 
Robustness Distilled water Stable Stable Stable Stable Stable 
HCl 0.1 N Stable Stable Stable Stable Stable 
Phosphate buffer pH 6.8 Stable Stable Stable Stable Stable 
Thermodynamic Centrifugation Stable Stable Stable Stable Stable 
Heating cooling Stable Stable Stable Stable Stable 
Freeze-thaw Stable Stable Stable Stable Unstable 
Conclusion Qualify Qualify Qualify Qualify Unqualify 
 
The F2D formula was further evaluated by determining 
an average of globules size and polydispersity index 
(PDI) of the nanoemulsion system. The results of globule 
size analysis using a particle size analyzer showed that 
CLO-SNEDDS (F2D) was able to form a nanoemulsion 
system after dilution with a globule size of 125 nm and a 
PDI value of 0.515. These results followed the globule size 
requirements for SNEDDS (20-200 nm) and PDI of <0.730. 
 




The CLO-SNEDDS preparation with the ratio of a 
surfactant and cosurfactant (2 : 1) and a ratio of oil and 
smix (1 : 6) had good physical characteristics based on 
%transmittance, dispersibility, robustness, and 
thermodynamic stability studies. The CLO-SNEDDS 
(F2D) preparation was able to produce a nanoemulsion 
system after dilution with a globule size of 125 nm and a 
PDI of 0.515. 
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